ImmunoPrecise Antibodies
IPA2.0700.00% ( 0.000 )
ImmunoPrecise Antibodies (IPA)
ImmunoPrecise Antibodies Ltd. operates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company. It discovers and dev...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 2.070
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 3.246
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- prnewswire · 14 hours ago
09:37 ETIPA Urges SEC to Complete National Framework for Registered Offerings
- prnewswire · Jun 16 at 07:45 AM
08:45 ETThe Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It
- StockTitan · May 17 at 11:35 PM
The Biology Came First. | IPA Stock News
- nasdaq · Apr 27 at 06:15 AM
FDA Grants Orphan Drug Designation To OSE's Pegrizeprument For Post-Heart Transplant Rejection
- MorningStar · Apr 19 at 04:40 PM
EpiBiologics Doses First Patient with EPI-326 Bispecific Antibody in Global Phase 1 Study for EGFR-Driven Solid Tumors
- GlobeNewswire · Apr 15 at 12:30 AM
OSE Immunotherapeutics to Present a Novel, First-in-Class, FPR2 Agonist Monoclonal Antibody in the Resolution of Chronic Inflammation at the AAI 2026 Meeting
